Clinical Trial Update: Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma [NA]

View source ↗

Summary

This document provides an update on a clinical trial evaluating sorafenib as adjuvant therapy followed by radiofrequency ablation for recurrent hepatocellular c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Southwest Hospital, China | Conditions: HCC | NA | Status: UNKNOWN